S762-0955 Screening compound: (8aR)-1-cyclopropyl-2,2-dioxo-N~4a~-[2-(1H-pyrazol-1-yl)ethyl]octahydro-2lambda~6~,1-benzothiazine-4a(2H)-carboxamide

S762-0955 Screening compound: (8aR)-1-cyclopropyl-2,2-dioxo-N~4a~-[2-(1H-pyrazol-1-yl)ethyl]octahydro-2lambda~6~,1-benzothiazine-4a(2H)-carboxamide
S762-0955 Screening compound: (8aR)-1-cyclopropyl-2,2-dioxo-N~4a~-[2-(1H-pyrazol-1-yl)ethyl]octahydro-2lambda~6~,1-benzothiazine-4a(2H)-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S762-0955
(8aR)-1-cyclopropyl-2,2-dioxo-N~4a~-[2-(1H-pyrazol-1-yl)ethyl]octahydro-2lambda~6~,1-benzothiazine-4a(2H)-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S762-0955

Molecular Formula

C17H26N4O3S (C17 H26 N4 O3 S)

Compound Name

(8aR)-1-cyclopropyl-2,2-dioxo-N~4a~-[2-(1H-pyrazol-1-yl)ethyl]octahydro-2lambda~6~,1-benzothiazine-4a(2H)-carboxamide

IUPAC name

(4aR8aR)-1-cyclopropyl-22-dioxo-N-[2-(1H-pyrazol-1-yl)ethyl]-octahydro-1H-2lambda61-benzothiazine-4a-carboxamide

SMILES

O=C([C@@](CCCC1)(CC2)[C@H]1N(C1CC1)S2(=O)=O)NCCn1nccc1

InChI

InChI=1S/C17H26N4O3S/c22-16(18-10-12-20-11-3-9-19-20)17-7-2-1-4-15(17)21(14-5-6-14)25(23,24)13-8-17/h3,9,11,14-15H,1-2,4-8,10,12-13H2,(H,18,22)/t15-,17-/m0/s1

InChI Key

XSXGPFGZYVETLE-RDJZCZTQSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

366.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

0.664

Distribution Coefficient, logD

0.664

Water Solubility, LogSw

-1.71

Polar Surface Area

70.693

Acid Dissociation Constant (pKa)

13.69

Base Dissociation Constant (pKb)

1.99

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

76.47

S762-0955 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with S762-0955 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S762-0955?
Check Price and Availability of S762-0955, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S762-0955 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S762-0955
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S762-0955
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S762-0955 available by request